title: The effect of dabigatran and rivarovaban on a prothrombinase-based assay for activated protein C resistance: a preliminary study in subjects heterozygous for factor V Leiden.
authors.affiliation: Transfusion Service, "Madonna della Navicella" Hospital, Chioggia, Italy.|Laboratory Medicine, "Madonna della Navicella" Hospital, Chioggia, Italy.
authors.forename: Gianluca
authors.initials: G
authors.lastname: Gessoni
authors.affiliation: Transfusion Service, "Madonna della Navicella" Hospital, Chioggia, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Valverde
authors.affiliation: Laboratory Medicine, "Madonna della Navicella" Hospital, Chioggia, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Gessoni
authors.affiliation: Cardiology and Coronary Unit, "Madonna della Navicella" Hospital, Chioggia, Italy.
authors.forename: Roberto
authors.initials: R
authors.lastname: Valle
mesh_terms: D020016:Activated Protein C Resistance / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D000368:Aged; D000369:Aged, 80 and over; D000991:Antithrombins / Q000494:pharmacology* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D000069604:Dabigatran / Q000494:pharmacology* / Q000627:therapeutic use; D005165:Factor V / Q000235:genetics*; D065427:Factor Xa Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D010314:Partial Thromboplastin Time; D000069552:Rivaroxaban / Q000494:pharmacology* / Q000627:therapeutic use; D013925:Thromboplastin
chemical_list: D000991:Antithrombins; D065427:Factor Xa Inhibitors; C095381:factor V Leiden; D005165:Factor V; D013925:Thromboplastin; D000069552:Rivaroxaban; D000069604:Dabigatran